Recently, USA Today featured an article about a new Left Ventricular Assist Device (LVAD) explaining how the advancements of the machine may save even more lives.
The HeartMate II is the second in a series of pumps designed to sustain heart-failure patients until a donor heart becomes available.
A souped-up successor to the HeartMate I, which offered patients only a short-lived reprieve, the HeartMate II has revived a dream that a mechanical device may serve effectively as a "destination" therapy for patients who can't find a donor heart or may not survive a transplant.
At NFT, we can assist patients with their LVAD expenses, as well as many other transplant-related expenses.
Click here to read more about the HeartMate II in USA Today.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment